GB1111433A - A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions - Google Patents
A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositionsInfo
- Publication number
- GB1111433A GB1111433A GB3652065A GB3652065A GB1111433A GB 1111433 A GB1111433 A GB 1111433A GB 3652065 A GB3652065 A GB 3652065A GB 3652065 A GB3652065 A GB 3652065A GB 1111433 A GB1111433 A GB 1111433A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hypnotic
- sedative
- urea
- potentiate
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000000147 hypnotic effect Effects 0.000 title abstract 2
- 230000003533 narcotic effect Effects 0.000 title abstract 2
- 239000000932 sedative agent Substances 0.000 title abstract 2
- 230000001624 sedative effect Effects 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 1
- JMBQKKAJIKAWKF-UHFFFAOYSA-N Glutethimide Chemical compound C=1C=CC=CC=1C1(CC)CCC(=O)NC1=O JMBQKKAJIKAWKF-UHFFFAOYSA-N 0.000 abstract 1
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 abstract 1
- 150000007945 N-acyl ureas Chemical class 0.000 abstract 1
- KSUUMAWCGDNLFK-UHFFFAOYSA-N apronal Chemical compound C=CCC(C(C)C)C(=O)NC(N)=O KSUUMAWCGDNLFK-UHFFFAOYSA-N 0.000 abstract 1
- 229960004459 apronal Drugs 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- OPNPQXLQERQBBV-UHFFFAOYSA-N carbromal Chemical compound CCC(Br)(CC)C(=O)NC(N)=O OPNPQXLQERQBBV-UHFFFAOYSA-N 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- 229960002972 glutethimide Drugs 0.000 abstract 1
- 229960002803 methaqualone Drugs 0.000 abstract 1
- BZRZRAJFBZQJRU-UHFFFAOYSA-N n-bromo-n-carbamoyl-3-methylbutanamide Chemical compound CC(C)CC(=O)N(Br)C(N)=O BZRZRAJFBZQJRU-UHFFFAOYSA-N 0.000 abstract 1
- 229960004554 phenglutarimide Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 238000011287 therapeutic dose Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3652065A GB1111433A (en) | 1965-08-25 | 1965-08-25 | A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions |
| FR46254A FR5021M (enExample) | 1965-08-25 | 1966-01-18 | |
| BE685950D BE685950A (enExample) | 1965-08-25 | 1966-08-24 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3652065A GB1111433A (en) | 1965-08-25 | 1965-08-25 | A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1111433A true GB1111433A (en) | 1968-04-24 |
Family
ID=10388906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3652065A Expired GB1111433A (en) | 1965-08-25 | 1965-08-25 | A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE685950A (enExample) |
| FR (1) | FR5021M (enExample) |
| GB (1) | GB1111433A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2138680A (en) * | 1983-04-29 | 1984-10-31 | Merrell Toraude & Co | Treatment of seizure disorders |
-
1965
- 1965-08-25 GB GB3652065A patent/GB1111433A/en not_active Expired
-
1966
- 1966-01-18 FR FR46254A patent/FR5021M/fr not_active Expired
- 1966-08-24 BE BE685950D patent/BE685950A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2138680A (en) * | 1983-04-29 | 1984-10-31 | Merrell Toraude & Co | Treatment of seizure disorders |
Also Published As
| Publication number | Publication date |
|---|---|
| FR5021M (enExample) | 1967-04-24 |
| BE685950A (enExample) | 1967-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL31146A0 (en) | 1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-diones,their preparation and pharmaceutical compositions containing them | |
| IL33526A (en) | Sulphamyl-benzoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL30282A (en) | 1,4-benzodiazepines and benzodiazepin-2-ones,their preparation and pharmaceutical compositions containing them | |
| IL35987A0 (en) | Vitamin a acid amides,their preparation and pharmaceutical compositions containing them | |
| GB1202148A (en) | Pharmaceutical compositions | |
| GB1111433A (en) | A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions | |
| IL35717A0 (en) | Quinoxaline-2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL30369A0 (en) | Aralkylthioamino acids,their preparation and pharmaceutical compositions containing them | |
| IL25542A (en) | Physiologically active compositions containing imidazopyridine derivatives and new imidazopyridine derivatives | |
| IL35490A (en) | 6-amidino-penicillanic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL35689A0 (en) | 2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them | |
| IL31294A0 (en) | A new(hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them | |
| IL30265A0 (en) | New piperidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL36102A0 (en) | Imidazolinyl substituted acetanilide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL28811A (en) | 1,3-disubstituted pyrrolidines,their preparation and pharmaceutical compositions containing them | |
| GB912738A (en) | New pharmaceutical compositions | |
| IL36096A0 (en) | 2,6-dimorpholino-pyrimido (5,4-d) pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
| GB1390452A (en) | Iron preparation | |
| IL26620A (en) | 1,2-dihydroquinoline-n-carboxylic and thionocarboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
| AU252959B2 (en) | A delayed release medicament preparation in oral dosage form and process for making the same | |
| GB1339636A (en) | Pharmaceutical compositions for inducing skeletal muscle relaxation | |
| IL29969A0 (en) | 1-substituted 3-arylsulfonyl ureas,their preparation and pharmaceutical use | |
| GB1454872A (en) | Anticonvulsant | |
| AU414340B2 (en) | Medicinal compositions for administration to animals and process for administering same | |
| IL32520A0 (en) | N-cinnamyl-n'-benzhydryl piperazines,their preparation and pharmaceutical compositions containing them |